Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2025-2033

Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3515

Market Overview:

The global drug discovery informatics market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 3.6 Billion
Market Forecast in 2033
USD 8.4 Billion
Market Growth Rate 2025-2033 9.21%


Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global drug discovery informatics market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

  • Drug Discovery
  • Drug Development
     

Breakup by Function:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Molecular Docking
  • Clinical Trial Data Management
  • Others
     

Breakup by Mode:

  • Outsourced
  • In-house
     

Breakup by End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Workflow, Function, Mode, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years ?
  • What has been the impact of COVID-19 on the global drug discovery informatics market ?
  • What are the key regional markets ?
  • What is the breakup of the market based on the workflow ?
  • What is the breakup of the market based on the function ?
  • What is the breakup of the market based on the mode ?
  • What is the breakup of the market based on the end user ?
  • What are the various stages in the value chain of the industry ?
  • What are the key driving factors and challenges in the industry ?
  • What is the structure of the global drug discovery informatics market and who are the key players ?
  • What is the degree of competition in the industry ?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials